Thomas Luu, Gilead
Thomas Luu of Gilead Sciences, director of global product security, leads anti-counterfeiting and trust efforts across pharmaceutical products. At Neo4j GraphTalk in San Francisco, John Furrier of theCUBE Research hosts a conversation on applying graph databases and artificial intelligence, referred to as AI below, to pharmaceutical fraud detection across global supply chains. Luu discusses converting relational data into graph representations and leveraging graph neural networks and knowledge graphs to detect fraud, waste and abuse across disparate data sources. They explain how graph models surface hidden networks and clusters that traditional relational analysis misses, improving explainability and investigator efficiency. They emphasize contextualizing signals with open source intelligence, referred to as OSINT below, and business knowledge to reduce false positives and to scale detection. The conversation highlights the need to operationalize graph platforms with cross-functional teams, analytics and AI agents for real-time explainable decisioning. This discussion provides practical insights for security, analytics and compliance professionals working on pharmaceutical supply chain integrity, data governance and fraud detection.